Omar Elghawy

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Epidermal Growth Factor Receptor

Basal Cell Carcinoma

Small Cell Lung Cancer

Pain Management

Top Venues

Current oncology (Toronto, Ont.)

Cancer reports (Hoboken, N.J.)

Obstetrics and gynecology international

Clinical journal of gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Philip Young, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D Gentzler, Linda W Martin, Wendy M Novicoff, Richard Hall
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 31 (1) (2024)
Omar Elghawy, Reema Patel, Adam Barsouk, Joe Puthumana, Jason Xu, Jonathan Sussman, Bethany Horton, Varinder Kaur
Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Philip Young, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D Gentzler, Linda W Martin, Wendy M Novicoff, Richard Hall
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 31 (1) (2024)
Omar Elghawy, Adam Barsouk, Alec Heidlauf, Simon Chen, Roger B Cohen, Lova L Sun
Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma. Journal of the Endocrine Society 8 (10) (2024)
Philip Young, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D Gentzler, Linda W Martin, Wendy M Novicoff, Richard Hall
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 31 (1) (2024)
Amrita Ladwa, Omar Elghawy, Varinder Kaur
Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas. Obstetrics and gynecology international 2024 (2024)
Reema Patel, Omar Elghawy, Amanda Gibbs, Srishti Gupta, Varinder Kaur
A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer reports (Hoboken, N.J.) 7 (7) (2024)
Angelo Angione, Jonathan Patterson, Ebrar Akca, Jessica Xu, Emily Xu, Vanessa Raab, Omar Elghawy, Adam A Barsouk, Jonathan H Sussman
A Cross-Sectional Analysis of Interventional Clinical Trials in High-Grade Glioma Therapy. Life (Basel, Switzerland) 14 (8) (2024)
Philip Young, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D Gentzler, Linda W Martin, Wendy M Novicoff, Richard Hall
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current oncology (Toronto, Ont.) 31 (1) (2024)
Amrita Ladwa, Omar Elghawy, Varinder Kaur
Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas. Obstetrics and gynecology international 2024 (2024)
Reema Patel, Omar Elghawy, Amanda Gibbs, Srishti Gupta, Varinder Kaur
A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma. Cancer reports (Hoboken, N.J.) 7 (7) (2024)
John Wang, Omar Elghawy, Brett Kurpiel, Varinder Kaur
Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clinical journal of gastroenterology (2023)
Heejin Cheon, Omar Elghawy, Bryna C Shemo, David J Feith, Thomas P Loughran
LGL leukemia patients exhibit substantial protective humoral responses following SARS-CoV-2 vaccination. EJHaem 3 (3) (2022)